Just Left There to Float: A Heightened Need for Collaboration with Stimulus Dollars Out Of Reach

Late last month, the federal government passed a $2.2 trillion package to keep the economy from sinking into a recession in the wake of COVID-19. Currently, there are stimulus package dollars being offered at the state, local, and federal levels. But what access does the cannabis industry have to these resources for economic assistance? Let's

By |2020-07-02T09:43:57-06:00April 16th, 2020|Bob's Voice|

Lighting of the Sun on Bright Unfocused Eyes: A Note on Repercussions from the DEA’s Descheduling of Epidiolex

On April 7th, the Drug Enforcement Administration announced that Epidiolex was no longer being treated as a controlled substance. To truly appreciate this, we need some background. In 2018, Epidiolex, which is manufactured by Britain-based GW Pharmaceuticals, was the first cannabis-formulated drug to be approved by the FDA. Epidiolex is used to treat seizures associated

By |2020-04-09T14:10:57-06:00April 9th, 2020|Bob's Voice|

If You Plant Ice, You’re Gonna Harvest Wind

Why Are Politicians Blocking Federal Banking Services for Legitimate Cannabusinesses? On February 13th, twelve members of the U.S. House of Representatives, including Reps. Ken Buck and Doug Lamborn from Colorado, sent a letter stirring further pessimism for cannabis banking to Chairman of the Senate Committee on Banking, Housing and Urban Affairs, Mike Crapo. Back in

By |2020-07-02T09:43:58-06:00March 25th, 2020|Bob's Voice|

 Deciphering Davos: Mobilizing Support for the Global Cannabis Economy

I spent a considerable amount of 2019 traveling across Latin America working with industry and government leaders to advance cannabis policy, connect transactions, and understand the emerging market for hemp and marijuana in LatAm. Near the tail end of last year, I was extended an invitation to participate in several events taking place at and

By |2020-03-11T09:57:26-06:00March 11th, 2020|Bob's Voice|

Is Marijuana a Tool to Lure Swing Voters?

Said he'd vote for the man who paid the biggest price The next day at the polls On February 10th, the Trump administration released the budget plan for fiscal year 2021. The plan attracted a lot of attention from cannabis industry actors because it would end existing policy protecting state medical marijuana programs from Justice

By |2020-03-04T09:10:59-07:00March 4th, 2020|Bob's Voice|

A Long Road to Legalization: How Mexico Will Fit in the Global Cannabis Economy

Cannabis legalization in Mexico carries substantial weight. Since the fall of Colombia’s cartels, Mexico’s have come to dominate the black market. For viewers of Netflix’s Narcos and Narcos: Mexico (like myself), the impact of the Drug War and the violent influence of cartels has become captivating subject matter to American audiences. The reality is even

By |2020-03-25T16:01:18-06:00February 27th, 2020|Bob's Voice|

Growing Pains Pt. 1 Emerging Patterns in the Recreational Marijuana Marketplace

The 2010s were a big decade for cannabis. As we entered 2020, twelve states had legalized adult-use, recreational marijuana. Forbes recently reported that eighteen states could join that number, totalling 30 by the end of this year. This movement was, of course, spurred by Colorado voters’ watershed passage of Amendment 64 back in 2012.  As

By |2020-07-07T13:50:52-06:00February 11th, 2020|Bob's Voice|

Once in awhile you get shown the light in the strangest of places, if you look at it right

Musings on the 2020 World Economic Forum in Davos  Last month, I traveled to Davos, Switzerland, as a guest of the world-class Cannatech crew for its annual event, which coincides with the World Economic Forum (WEF). I attended the Cannabis Conclave for discussions on European Union-based data, policy, and the work of the cannabis advocacy

By |2020-02-05T09:22:45-07:00February 5th, 2020|Bob's Voice|
Go to Top